This post provides a detailed analysis of the patentability of biotech inventions in Europe under the EPC and EU Biotechnology Directive. It covers exclusions, key legal requirements, and the influence of morality on patent decisions, with reference to significant European cases.
Read more about Patentability of Biotech Inventions in EuropeTag: Gene Patents
Life of a Gene in India
This analysis addresses the uncertain legal landscape for gene patents in India, with a focus on isolated and purified gene sequences. The author calls for clearer guidelines and consistent application of patent law by the Indian Patent Office.
Read more about Life of a Gene in IndiaGene Sequences and Patents: Australian High Court Narrows Scope
The Australian High Court has narrowed the eligibility of gene patents, particularly concerning isolated DNA sequences in the BRCA1 case. This analysis explores the legal reasoning, statutory interpretation, and global impact on biotechnology patent law, following similar US Supreme Court decisions.
Read more about Gene Sequences and Patents: Australian High Court Narrows ScopeThe 3D Effect of Novartis Case on Genetic Inventions
The Novartis case established a strict test for therapeutic efficacy under Section 3(d) of the Indian Patents Act, influencing the patentability of genetic inventions. This post examines the impact on gene sequence patents and the ongoing legal debate regarding their compliance with Indian patent law.
Read more about The 3D Effect of Novartis Case on Genetic Inventions